Analystreport

Cellectis S.A. (NASDAQ: CLLS) is now covered by analysts at Bryan, Garnier & Co. They set a "buy" rating and a $6.00 price target on the stock.

Cellectis S.A. - American Depositary Shares  (CLLS) 
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors